Global Noninvasive Cancer Diagnostics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Noninvasive Cancer Diagnostics Revenue
• 1.4 Market by Type
  • 1.4.1 Global Noninvasive Cancer Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Clinical Chemistry
  • 1.4.3 Immunochemistry/Immunoassay
  • 1.4.4 Molecular Diagnostics
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Noninvasive Cancer Diagnostics Market Share by Application: 2020 VS 2026
  • 1.5.2 Solid Tumors
  • 1.5.3 Blood Cancer
  • 1.5.4 Lung Cancer
  • 1.5.5 Breast Cancer
  • 1.5.6 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Noninvasive Cancer Diagnostics Market Perspective (2015-2026)
• 2.2 Global Noninvasive Cancer Diagnostics Growth Trends by Regions
  • 2.2.1 Noninvasive Cancer Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Noninvasive Cancer Diagnostics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Noninvasive Cancer Diagnostics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Noninvasive Cancer Diagnostics Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Noninvasive Cancer Diagnostics Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Noninvasive Cancer Diagnostics Players by Market Size
  • 3.1.1 Global Top Noninvasive Cancer Diagnostics Players by Revenue (2015-2020)
  • 3.1.2 Global Noninvasive Cancer Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Noninvasive Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Noninvasive Cancer Diagnostics Market Concentration Ratio
  • 3.2.1 Global Noninvasive Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Noninvasive Cancer Diagnostics Revenue in 2019
• 3.3 Noninvasive Cancer Diagnostics Key Players Head office and Area Served
• 3.4 Key Players Noninvasive Cancer Diagnostics Product Solution and Service
• 3.5 Date of Enter into Noninvasive Cancer Diagnostics Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Noninvasive Cancer Diagnostics Historic Market Size by Type (2015-2020)
• 4.2 Global Noninvasive Cancer Diagnostics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Noninvasive Cancer Diagnostics Market Size by Application (2015-2020)
• 5.2 Global Noninvasive Cancer Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Noninvasive Cancer Diagnostics Market Size (2015-2020)
• 6.2 Noninvasive Cancer Diagnostics Key Players in North America (2019-2020)
• 6.3 North America Noninvasive Cancer Diagnostics Market Size by Type (2015-2020)
• 6.4 North America Noninvasive Cancer Diagnostics Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Noninvasive Cancer Diagnostics Market Size (2015-2020)
• 7.2 Noninvasive Cancer Diagnostics Key Players in Europe (2019-2020)
• 7.3 Europe Noninvasive Cancer Diagnostics Market Size by Type (2015-2020)
• 7.4 Europe Noninvasive Cancer Diagnostics Market Size by Application (2015-2020)

8 China

• 8.1 China Noninvasive Cancer Diagnostics Market Size (2015-2020)
• 8.2 Noninvasive Cancer Diagnostics Key Players in China (2019-2020)
• 8.3 China Noninvasive Cancer Diagnostics Market Size by Type (2015-2020)
• 8.4 China Noninvasive Cancer Diagnostics Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Noninvasive Cancer Diagnostics Market Size (2015-2020)
• 9.2 Noninvasive Cancer Diagnostics Key Players in Japan (2019-2020)
• 9.3 Japan Noninvasive Cancer Diagnostics Market Size by Type (2015-2020)
• 9.4 Japan Noninvasive Cancer Diagnostics Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Noninvasive Cancer Diagnostics Market Size (2015-2020)
• 10.2 Noninvasive Cancer Diagnostics Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Noninvasive Cancer Diagnostics Market Size by Type (2015-2020)
• 10.4 Southeast Asia Noninvasive Cancer Diagnostics Market Size by Application (2015-2020)

11 India

• 11.1 India Noninvasive Cancer Diagnostics Market Size (2015-2020)
• 11.2 Noninvasive Cancer Diagnostics Key Players in India (2019-2020)
• 11.3 India Noninvasive Cancer Diagnostics Market Size by Type (2015-2020)
• 11.4 India Noninvasive Cancer Diagnostics Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Noninvasive Cancer Diagnostics Market Size (2015-2020)
• 12.2 Noninvasive Cancer Diagnostics Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Noninvasive Cancer Diagnostics Market Size by Type (2015-2020)
• 12.4 Central & South America Noninvasive Cancer Diagnostics Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Precision Therapeutics, Inc. (U.S.)
  • 13.1.1 Precision Therapeutics, Inc. (U.S.) Company Details
  • 13.1.2 Precision Therapeutics, Inc. (U.S.) Business Overview
  • 13.1.3 Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
  • 13.1.4 Precision Therapeutics, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2015-2020))
  • 13.1.5 Precision Therapeutics, Inc. (U.S.) Recent Development
• 13.2 A&G Pharmaceutical, Inc. (U.S.)
  • 13.2.1 A&G Pharmaceutical, Inc. (U.S.) Company Details
  • 13.2.2 A&G Pharmaceutical, Inc. (U.S.) Business Overview
  • 13.2.3 A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
  • 13.2.4 A&G Pharmaceutical, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2015-2020)
  • 13.2.5 A&G Pharmaceutical, Inc. (U.S.) Recent Development
• 13.3 Affymetrix Inc. (U.S.)
  • 13.3.1 Affymetrix Inc. (U.S.) Company Details
  • 13.3.2 Affymetrix Inc. (U.S.) Business Overview
  • 13.3.3 Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
  • 13.3.4 Affymetrix Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2015-2020)
  • 13.3.5 Affymetrix Inc. (U.S.) Recent Development
• 13.4 AVIVA Biosciences Corporation (U.S.)
  • 13.4.1 AVIVA Biosciences Corporation (U.S.) Company Details
  • 13.4.2 AVIVA Biosciences Corporation (U.S.) Business Overview
  • 13.4.3 AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Introduction
  • 13.4.4 AVIVA Biosciences Corporation (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2015-2020)
  • 13.4.5 AVIVA Biosciences Corporation (U.S.) Recent Development
• 13.5 BIOVIEW Inc. (U.S.)
  • 13.5.1 BIOVIEW Inc. (U.S.) Company Details
  • 13.5.2 BIOVIEW Inc. (U.S.) Business Overview
  • 13.5.3 BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
  • 13.5.4 BIOVIEW Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2015-2020)
  • 13.5.5 BIOVIEW Inc. (U.S.) Recent Development
• 13.6 Laboratory Corporation of America Holdings (LabCorp) (U.S.)
  • 13.6.1 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Company Details
  • 13.6.2 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Business Overview
  • 13.6.3 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Introduction
  • 13.6.4 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2015-2020)
  • 13.6.5 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Recent Development
• 13.7 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.)
  • 13.7.1 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Company Details
  • 13.7.2 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Business Overview
  • 13.7.3 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
  • 13.7.4 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2015-2020)
  • 13.7.5 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Recent Development
• 13.8 Digene Corporation (U.S.)
  • 13.8.1 Digene Corporation (U.S.) Company Details
  • 13.8.2 Digene Corporation (U.S.) Business Overview
  • 13.8.3 Digene Corporation (U.S.) Noninvasive Cancer Diagnostics Introduction
  • 13.8.4 Digene Corporation (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2015-2020)
  • 13.8.5 Digene Corporation (U.S.) Recent Development
• 13.9 Gen-Probe Incorporated (U.S.)
  • 13.9.1 Gen-Probe Incorporated (U.S.) Company Details
  • 13.9.2 Gen-Probe Incorporated (U.S.) Business Overview
  • 13.9.3 Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Introduction
  • 13.9.4 Gen-Probe Incorporated (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2015-2020)
  • 13.9.5 Gen-Probe Incorporated (U.S.) Recent Development
• 13.10 IVDiagnostics, Inc. (U.S.)
  • 13.10.1 IVDiagnostics, Inc. (U.S.) Company Details
  • 13.10.2 IVDiagnostics, Inc. (U.S.) Business Overview
  • 13.10.3 IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
  • 13.10.4 IVDiagnostics, Inc. (U.S.) Revenue in Noninvasive Cancer Diagnostics Business (2015-2020)
  • 13.10.5 IVDiagnostics, Inc. (U.S.) Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer